YOLFTbeta
ZeroStack Corp.

ZeroStack Corp.

ZSTK · NASDAQ · Financial Services / Asset Management

2.74USD+0.23 (+9.16%)

Price History

Full chart

Market Stats

Previous Close2.51
Open2.48
Day Range2.48 – 2.93
52-Week Range1.32 – 20.45
Volume38.81K
Market Cap105.50M
P/E (TTM)0.00
Forward P/E7.89
EPS-44.63
Dividend Yield0.00%
Beta2.05
50-Day Avg3.49
200-Day Avg5.56

About

ZeroStack Corp., through its subsidiary, Phatebo GmbH, engages in the pharmaceutical distribution business in Germany. It operates through Commercial & Wholesale and Digital Assets segments. The company distributes a range of pharmaceutical goods and medical products to treat various health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. It also operates as a decentralized AI treasury company that invests in the future of AI infrastructure through strategic ownership of 0G tokens. In addition, the company invests in early-stage companies. The company was formerly known as Flora Growth Corp. and changed its name to ZeroStack Corp. in January 2026. ZeroStack Corp. was incorporated in 2019 and is based in Toronto, Canada.

Company Details

  • SectorFinancial Services
  • IndustryAsset Management
  • CEOMr. Daniel Reis-Faria
  • Employees21
  • Headquarters40 King Street W, Toronto, ON, Canada, M5H 3Y2, USA
  • Websitehttps://zerostack.ai

Leadership

  • Mr. Michael HeinrichExecutive Chairman · b. 1984
  • Mr. Daniel Reis-FariaCEO & Director · b. 1990
  • Mr. Dany VaimanChief Financial Officer · b. 1986
  • Mr. Rudy RongPresident
  • Dr. Manfred ZieglerManaging Director · b. 1962
  • Mr. Patrick MoloneyHead of Product Development
  • Mr. Aaron AtinCorporate Secretary · b. 1985

Financials

Income Statement

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue-106.00K8.98M33.40M76.07M59.51M35.68M
Growth (%)--+8371.70%+271.95%+127.75%-21.78%-40.05%
Cost of Revenue25.86K35.00K6.55M20.15M58.33M47.01M40.50M
Gross Profit-25.86K71.00K2.42M13.25M17.74M12.50M-4.82M
Gross Margin-66.98%27.00%39.67%23.32%21.00%-13.51%
Operating Expense2.79M14.36M21.43M60.47M68.09M28.14M4.74M
Operating Income-2.82M-14.28M-19.00M-47.22M-50.35M-15.64M-9.56M
Operating Margin--13475.47%-211.61%-141.38%-66.19%-26.29%-26.80%
EBITDA-2.80M-14.19M-20.93M-17.87M-45.87M-15.10M-8.98M
EBITDA Margin--13387.74%-233.03%-53.50%-60.30%-25.38%-25.17%
Net Income-2.84M-14.17M-21.25M-52.41M-57.04M-15.91M-120.85M
Net Income Margin--13367.92%-236.63%-156.93%-74.98%-26.73%-338.75%
R&D21.04K78.00K132.00K388.00K62.00K418.00K238.00K
R&D as % of Total Revenue-73.58%1.47%1.16%0.08%0.70%0.67%
Interest Expense19.48K30.00K32.00K-92.00K213.00K199.00K
Interest Expense % of Total Revenue-28.30%0.36%-0.12%0.36%0.56%

Balance Sheet

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets1.17M19.45M85.48M80.99M23.63M26.23M130.24M
Total Liabilities2.48M3.20M8.54M24.57M17.22M21.72M59.68M
Total Equity-1.29M16.36M77.17M56.82M6.40M4.51M70.55M
Cash140.00K15.52M37.61M8.94M4.35M6.02M5.62M
Total Debt1.33M649.00K1.34M3.76M3.67M4.90M53.93M
Net Debt1.19M-14.87M-36.28M-5.17M-678.00K-1.12M48.31M

Cash Flow

Currency: USD2019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-453.82K-8.42M-20.65M-15.94M-8.40M-5.03M-8.68M
Investing Cash Flow-431.23K-2.16M-14.55M-15.80M-234.00K203.00K-3.46M
Financing Cash Flow1.00M25.82M58.11M4.41M3.15M6.49M11.35M
Capital Expenditure140.17K234.00K3.98M1.29M163.00K134.00K127.00K
Free Cash Flow-593.99K-8.65M-24.63M-17.23M-8.56M-5.17M-8.80M
Dividends Paid--0----
FCF to OCF130.89%102.78%119.29%108.12%101.94%102.66%101.46%
Dividend Paid to FCF--0.00%----

Earnings

Report DateMar 22, 2021May 12, 2021Aug 19, 2021Dec 1, 2021May 8, 2022Aug 14, 2022Nov 27, 2022Mar 31, 2023May 15, 2023Aug 9, 2023Nov 8, 2023Mar 28, 2024May 15, 2024Aug 12, 2024Nov 13, 2024Mar 24, 2025May 13, 2025Aug 1, 2025Nov 5, 2025Feb 27, 2026May 4, 2026Jul 31, 2026Nov 4, 2026
EPS Estimate0.00-0.04-0.01-0.05-0.02-19.50-0.06-0.07-27.30-23.40-7.80-2.73--0.78-3.12-0.011.17-2.34-2.13-0.39--0.11-
EPS Actual-0.05-0.34-1.40-0.60-54.60-46.80-39.00-3.20-17.39-28.05-1.94-31.98-14.76-9.68-8.37-0.42-1.99-4.54-4.93-34.29-3.68-2.47-
Surprise--750.00%-9233.33%-1100.00%-326846.11%-140.00%-64900.00%-4332.13%36.30%-19.87%75.13%-1071.43%--1141.03%-168.27%-4100.00%-270.09%-94.02%-131.46%-8692.31%--2145.45%-
Timing----After-hoursAfter-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hours-After-hoursAfter-hours-After-hoursAfter-hoursAfter-hoursAfter-hours-After-hours-

Key Statistics & Ratios

Market Cap105.50M
Enterprise Value85.56M
Trailing P/E0.00
Forward P/E7.89
Price / Sales2.64
Price / Book6.18
EPS-44.63
Book Value5.69
Revenue (TTM)40.03M
Gross Profit (TTM)5.26M
EBITDA-12.56M
Profit Margin0.00%
Operating Margin-18.08%
Return on Equity-1959.59%
Return on Assets-33.36%
Shares Outstanding21.80M
Shares Float6.12M
Beta2.05
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
0.40%
Insiders
83.60%
Retail / Other
16.00%

Top Institutional Holders

  • Vanguard Capital Management, LLC
    25.44K0.12%
  • Geode Capital Management, LLC
    25.32K0.12%
  • Vanguard Fiduciary Trust Co
    12.65K0.06%
  • UBS Group AG
    6660.00%
  • Morgan Stanley - Brokerage Accounts
    1730.00%
  • Mercer Global Advisors Inc.
    250.00%
  • Royal Bank of Canada
    120.00%
  • Advisor Group Holdings, Inc.
    120.00%
  • KEY Financial, INC.
    10.00%
  • Sound Income Strategies
    00.00%
  • Creekmur Asset Management LLC
    00.00%
  • Tower Research Capital LLC
    00.00%
  • Bank of America Corp
    00.00%

Top Fund Holders

  • Fidelity Extended Market Index
    13.34K0.06%
  • Fidelity Series Total Market Index
    2.28K0.01%
  • Fidelity Total Market Index
    1.49K0.01%
  • Fidelity Nasdaq Composite Index
    1330.00%

Stock Splits

  • Aug 4, 20251:39
  • Jun 9, 20231:20